Long-Term Physical (In)Stability of Spray-Dried Amorphous Drugs: Relationship with Glass-Forming Ability and Physicochemical Properties

被引:23
作者
Edueng, Khadijah [1 ,2 ]
Bergstrom, Christel A. S. [1 ]
Grasjo, Johan [1 ]
Mahlin, Denny [1 ,3 ]
机构
[1] Uppsala Univ, Dept Pharm, Husargatan 3, S-75123 Uppsala, Sweden
[2] Int Islamic Univ Malaysia, Kulliyyah Pharm, Jalan Istana, Bandar Indera Mahkota 25200, Kuantan Pahang, Malaysia
[3] AstraZeneca, S-15185 Sodertalje, Sweden
基金
瑞典研究理事会; 欧洲研究理事会;
关键词
long-term stability; amorphous; glass-forming ability; glass stability; physicochemical properties; crystallization; spray-drying; humidity; melt-quenching; CRYSTALLIZATION TENDENCY; TRANSITION TEMPERATURE; STABILITY; PREDICTIONS; STATE; WATER; CLASSIFICATION; DISSOLUTION; SELECTION; MOBILITY;
D O I
10.3390/pharmaceutics11090425
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study shows the importance of the chosen method for assessing the glass-forming ability (GFA) and glass stability (GS) of a drug compound. Traditionally, GFA and GS are established using in situ melt-quenching in a differential scanning calorimeter. In this study, we included 26 structurally diverse glass-forming drugs (i) to compare the GFA class when the model drugs were produced by spray-drying with that when melt-quenching was used, (ii) to investigate the long-term physical stability of the resulting amorphous solids, and (iii) to investigate the relationship between physicochemical properties and the GFA of spray-dried solids and their long-term physical stability. The spray-dried solids were exposed to dry (<5% RH) and humid (75% RH) conditions for six months at 25 degrees C. The crystallization of the spray-dried solids under these conditions was monitored using a combination of solid-state characterization techniques including differential scanning calorimetry, Raman spectroscopy, and powder X-ray diffraction. The GFA/GS class assignment for 85% of the model compounds was method-dependent, with significant differences between spray-drying and melt-quenching methods. The long-term physical stability under dry condition of the compounds was predictable from GFA/GS classification and glass transition and crystallization temperatures. However, the stability upon storage at 75% RH could not be predicted from the same data. There was no strong correlation between the physicochemical properties explored and the GFA class or long-term physical stability. However, there was a slight tendency for compounds with a relatively larger molecular weight, higher glass transition temperature, higher crystallization temperature, higher melting point and higher reduced glass transition temperature to have better GFA and better physical stability. In contrast, a high heat of fusion and entropy of fusion seemed to have a negative impact on the GFA and physical stability of our dataset.
引用
收藏
页数:20
相关论文
共 32 条
[1]   Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability [J].
Alhalaweh, Amjad ;
Alzghoul, Ahmad ;
Mahlin, Denny ;
Bergstrom, Christel A. S. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 495 (01) :312-317
[2]   Computational Predictions of Glass-Forming Ability and Crystallization Tendency of Drug Molecules [J].
Alhalaweh, Amjad ;
Alzghoul, Ahmad ;
Kaialy, Waseem ;
Mahlin, Denny ;
Bergstrom, Christel A. S. .
MOLECULAR PHARMACEUTICS, 2014, 11 (09) :3123-3132
[3]   Role of Viscosity in Influencing the Glass-Forming Ability of Organic Molecules from the Undercooled Melt State [J].
Baird, Jared A. ;
Santiago-Quinonez, Darlene ;
Rinaldi, Carlos ;
Taylor, Lynne S. .
PHARMACEUTICAL RESEARCH, 2012, 29 (01) :271-284
[4]   A Classification System to Assess the Crystallization Tendency of Organic Molecules from Undercooled Melts [J].
Baird, Jared A. ;
Van Eerdenbrugh, Bernard ;
Taylor, Lynne S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (09) :3787-3806
[5]   Glass Forming Ability of Amorphous Drugs Investigated by Continuous Cooling and Isothermal Transformation [J].
Blaabjerg, Lasse I. ;
Lindenberg, Eleanor ;
Lobmann, Korbinian ;
Grohganz, Holger ;
Rades, Thomas .
MOLECULAR PHARMACEUTICS, 2016, 13 (09) :3318-3325
[6]   Influence of preparation pathway on the glass forming ability [J].
Blaabjerg, Lasse Ingerslev ;
Lindenberg, Eleanor ;
Rades, Thomas ;
Grohganz, Holger ;
Lobmann, Korbinian .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 521 (1-2) :232-238
[7]   Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions [J].
Botker, Johan P. ;
Karmwar, Pranav ;
Strachan, Clare J. ;
Cornett, Claus ;
Tian, Fang ;
Zujovic, Zoran ;
Rantanen, Jukka ;
Rades, Thomas .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 417 (1-2) :112-119
[8]   The Need for Restructuring the Disordered Science of Amorphous Drug Formulations [J].
Edueng, Khadijah ;
Mahlin, Denny ;
Bergstrom, Christel A. S. .
PHARMACEUTICAL RESEARCH, 2017, 34 (09) :1754-1772
[9]   Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways [J].
Edueng, Khadijah ;
Mahlin, Denny ;
Larsson, Per ;
Bergstrom, Christel A. S. .
JOURNAL OF CONTROLLED RELEASE, 2017, 256 :193-202
[10]   Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin [J].
Graeser, Kirsten A. ;
Strachan, Clare J. ;
Patterson, James E. ;
Gordon, Keith C. ;
Rades, Thomas .
CRYSTAL GROWTH & DESIGN, 2008, 8 (01) :128-135